Repeatable
Two executions of the frozen synthetic fixture produced byte-identical Source-Linked Evidence Summary output under fixed execution anchors.
See the pattern. Understand the context. Communicate what matters.
SuperstarIQ is a consumer-directed health and wellness data and evidence technology platform in development. Independent Validation Readiness is the current phase. On September 17, 2026, Restarting The Heart completed a bounded deterministic MVP-0 engineering validation of the Source-Linked Evidence Summary pipeline using a frozen synthetic fixture and recorded execution anchors. The result demonstrates repeatability for that specific development slice; independent qualification remains the next evidence gate.
Evidence boundary: The MVP-0 milestone is not clinical validation, Critical-20 or Gate B qualification, production identifiable-health-data authorization, cloud-model authorization, or approval for external/public interactive deployment.
September 17, 2026 engineering milestone
RTH treats evidence states as separate gates. A development result is not automatically promoted into qualification, production, clinical, or release evidence.
Two executions of the frozen synthetic fixture produced byte-identical Source-Linked Evidence Summary output under fixed execution anchors.
The result was bound to versioned code, context, host and RTHBench trace/validation records rather than treated as an unanchored demo.
Negative controls reject malformed lineage, unauthorized routes and egress, missing authorization references, and improper promotion of a development host or result.
The pass applies to the recorded deterministic development slice. Independent sealed-holdout construction and later qualification remain separate work.
From fragmented information to a review-ready picture
What SuperstarIQ is being built to do
Bring fragmented observations, wearable data, symptoms, notes, and supporting information into a structured longitudinal view.
Review changes over time and compare trends to the individual’s own prior patterns.
Show where information came from, how recent it is, what is uncertain, and where sources conflict.
Create structured summaries that help users prepare for conversations with trusted professionals.
Evidence first
Source-Linked Evidence Summary
A structured evidence summary designed to help organize complex longitudinal information for review and communication. It does not diagnose or recommend treatment.
Development update · October 2026
Since the September MVP-0 milestone, a bounded local synthetic browser workflow has exercised observation loading, a Source-Linked Evidence Summary view, session cleanup, and rejection of a revoked token. These are development and security-test observations on a controlled host, not proof of safe operation with real health data or an independently qualified product.
A separate trust-and-assurance product in development. Its design explores how requests, authority, execution, evidence, and changes can be distinguished and traced. Design and synthetic tests do not establish independent assurance, certification, or live enforcement.
Learn about SIQTA →A separately governed future product concept, provisionally called SuperstarIQ Memory, has a synthetic-only internal app prototype. It explores explicit task confirmation and an Activity Memory record. Device alarm reliability, real-data use, external testing, and release are not established.
RTH is developing synthetic educational visual experiences to explain the ecosystem and source-linked evidence. These are not live product interfaces or substitutes for validation; public interactive versions require separate review and authorization.
Current boundary: least-privilege authority and independent technical, security, accessibility, privacy, and claims review remain open where applicable. No production identifiable-health-data use, clinical reliance, external pilot, or public interactive launch is implied.
Next evidence phase
Construct a prospectively designed sealed holdout under independent authorship, custody, screening, and contamination controls.
Discuss validation, interoperability, evidence methodology, human review, and responsible evaluation opportunities.
Receive product-development and research updates and future pilot invitations when applicable gates are satisfied.
Join the Waitlist →SuperstarIQ remains in development, with Independent Validation Readiness as the current phase. The September 17, 2026 MVP-0 result is a bounded deterministic engineering milestone, not clinical validation or production authorization. SuperstarIQ is not intended for diagnosis, treatment, emergency response, clinical clearance, or clinical reliance. Wearable and self-reported information may be incomplete or inaccurate.